23/01/2026
📕 𝗩𝗼𝗻 𝗛𝗶𝗽𝗽𝗲𝗹–𝗟𝗶𝗻𝗱𝗮𝘂 (𝗩𝗛𝗟) 𝗗𝗶𝘀𝗲𝗮𝘀𝗲
Von Hippel–Lindau disease is a rare autosomal dominant multisystem genetic disorder characterized by the development of multiple benign and malignant tumors in the CNS and visceral organs, especially involving the brain, spinal cord, retina, kidneys, pancreas, and adrenal glands.
♠️ 𝗚𝗲𝗻𝗲𝘁𝗶𝗰𝘀 / 𝗣𝗮𝘁𝗵𝗼𝗽𝗵𝘆𝘀𝗶𝗼𝗹𝗼𝗴𝘆
▪️Caused by mutation in the VHL tumor suppressor gene (chromosome 3p)
▪️Leads to uncontrolled angiogenesis and tumor formation
▪️Autosomal dominant inheritance with high penetrance
▪️Patients develop multiple tumors and cysts over their lifetime
♠️ 𝗖𝗼𝗺𝗺𝗼𝗻 𝗔𝗳𝗳𝗲𝗰𝘁𝗲𝗱 𝗢𝗿𝗴𝗮𝗻𝘀 & 𝗟𝗲𝘀𝗶𝗼𝗻𝘀
▪️CNS: Hemangioblastomas (cerebellum, spinal cord, brainstem)
▪️Eye: Retinal hemangioblastomas
▪️Kidneys: Renal cell carcinoma, renal cysts
▪️Pancreas: Pancreatic cysts, serous cystadenoma, neuroendocrine tumors
▪️Adrenals: Pheochromocytoma
▪️Epididymis/Broad ligament: Papillary cystadenoma
♠️ 𝗨𝗹𝘁𝗿𝗮𝘀𝗼𝘂𝗻𝗱 & 𝗜𝗺𝗮𝗴𝗶𝗻𝗴 𝗙𝗶𝗻𝗱𝗶𝗻𝗴𝘀
▪️Kidneys: Multiple renal cysts or solid masses (suspicious for RCC)
▪️Pancreas: Multiple cysts, sometimes solid neuroendocrine tumors
▪️Adrenals: Solid adrenal mass suggestive of pheochromocytoma
▪️CNS (MRI preferred): Cystic lesions with enhancing mural nodule (classic hemangioblastoma appearance)
♠️ 𝗖𝗹𝗶𝗻𝗶𝗰𝗮𝗹 𝗙𝗲𝗮𝘁𝘂𝗿𝗲𝘀
▪️Headache, ataxia, vomiting (due to cerebellar hemangioblastoma)
▪️Visual disturbance (retinal lesions)
▪️Hypertension, palpitations (pheochromocytoma)
▪️Hematuria or flank pain (renal involvement)
♠️ 𝗣𝗿𝗼𝗴𝗻𝗼𝘀𝗶𝘀 & 𝗠𝗮𝗻𝗮𝗴𝗲𝗺𝗲𝗻𝘁
▪️Requires lifelong surveillance
▪️Prognosis depends on early detection and treatment of RCC and CNS tumors
▪️Management includes surgical resection, embolization, or targeted therapy depending on lesion type
▪️Family members should undergo genetic screening
💡
Think of VHL disease when you see multiple cysts or tumors in kidneys, pancreas, and CNS together, especially in young patients, it is a systemic tumor syndrome, not a single-organ disease.